1. Xu DM,
van der Zaag-Loonen HJ,
Oudkerk M,
Wang Y,
Vliegenthart R,
Scholten ET,
et al(2009) Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up.
Radiology 250(1):264-272.
2. MacMahon H,
Austin JH,
Gamsu G,
Herold CJ,
Jett JR,
Naidich DP,
et al(2005)Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society.
Radiology 237(2):395-400.
3. Revel MP,
Merlin A,
Peyrard S,
Triki R,
Couchon S,
Chatellier G,et al(2006)Software volumetric evaluation of doubling times for differentiating benign versus malignant pulmonary nodules.
AJR Am J Roentgenol 187(1):135-142.
4. Bach PB,
Mirkin JN,
Oliver TK,
Azzoli CG,
Berry DA,
Brawley OW,
et al(2012)Benefits and harms of CT screening for lung cancer: a systematic review.
JAMA 307(22):2418-2429.
5. de Hoop B,
van Ginneken B,
Gietema H,
Prokop M(2012)Pulmonary perifissural nodules on CT scans: rapid growth is not a predictor of malignancy.
Radiology 265(2):611-616.
6. National Lung Screening Trial Research Team,
Aberle DR,
Adams AM,
Berg CD,
Black WC,
Clapp JD,
et al(2011)Reduced lung-cancer mortality with low-dose computed tomographic screening.
N Engl J Med 365(5):395-409.
7. Wender R,
Fontham ET,
Barrera E Jr,
Colditz GA,
Church TR,
Ettinger DS,
et al(2013) American Cancer Society lung cancer screening guidelines.
CA Cancer J Clin 63(2):107-117.
8. Winer-Muram HT(2006)The solitary pulmonary nodule.
Radiology 239(1):34-49
9. Jensen KG,
Schiodt T(1958)Growth conditions of hamartoma of the lung: a study based on 22 cases operated on after radiographic observation for from one to 18 years.
Thorax 13(3):233-237.
10. Lindell RM,
Hartman TE,
Swensen SJ,
Jett JR,
Midthun DE,
Mandrekar JN(2009)5-year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type,
CT attenuation,
stage,
survival,
and size.
Chest 136(6):1586-1595.
11. M.
Schwartz(1961)A biomathematical approach to clinical tumor growth.
Cancer 14:1272–1294.
12. Gould MK,
Donington J,
Lynch WR,
Mazzone PJ,
Midthun DE,
Naidich DP,
et al(2013) Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer,
3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Chest 143(5 Suppl):e93S-120S.
13. Hasegawa M,
Sone S,
Takashima S,
Li F,
Yang ZG,
Maruyama Y,
et al(2000)Growth rate of small lung cancers detected on mass CT screening.
Br J Radiol 73(876):1252-1259.
14. Henschke CI,
Yankelevitz DF,
Yip R,
Reeves AP,
Farooqi A,
Xu D,
et al(2012)Lung cancers diagnosed at annual CT screening: volume doubling times.
Radiology 263(2):578-583.
15. Swensen SJ,
Viggiano RW,
Midthun DE,
Müller NL,
Sherrick A,
Yamashita K,
et al(2000)Lung nodule enhancement at CT: multicenter study.
Radiology 214(1):73-80.
16. Ko JM,
Park HJ,
Kim CH(2014)Pulmonary changes of pleural TB: up-to-date CT imaging.
Chest 146(6):1604-1611.
17. MacMahon H,
Austin JH,
Gamsu G,
Herold CJ,
Jett JR,
Naidich DP,
et al(2005)Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society.
Radiology 237(2):395-400.
18. Georgiadou SP,
Sipsas NV,
Marom EM,
Kontoyiannis DP(2011)The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts.
Clin Infect Dis 52(9):1144-1155.
19. Shin SY,
Kim MY,
Oh SY,
Lee HJ,
Hong SA,
Jang SJ,
et al(2015)Pulmonary sclerosing pneumocytoma of the lung: CT characteristics in a large series of a tertiary referral center.
Medicine (Baltimore) 94(4):e498.
20.
Godoy MC,
Viswanathan C,
Marchiori E,
Truong MT,
Benveniste MF,
Rossi S,
et al(2012)The reversed halo sign: update and differential diagnosis.
Br J Radiol 85(1017):1226-1235.